益生菌对接受固定牙科治疗的患者疼痛和的作用
Tannaz Abdollahzadeh Baghaei1, Katayoun Katebi2, Mahsa Jafari Tayebpour3
1Department of Orthodontics, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran.
概括
这项研究发现,Lactogum益生菌药片在接受固定牙科治疗的患者中显著降低了疼痛和口腔. 建议进行进一步的临床试验,以证实这些积极的发现.
科学领域:
- 口腔健康研究 口腔健康研究
- 微生物组和口腔粘膜健康
- ортодонтической治疗并发症 牙科治疗并发症
背景情况:
- 创伤性口腔是固定牙科器械患者的常见问题.
- 目前用于器械引起的的治疗方法需要改进,以提高患者的舒适度.
- 益生菌在治疗与正牙相关的口腔不适的有效性正在研究中.
研究的目的:
- 为了评估Lactogum益生菌药片在减轻疼痛和的有效性.
- 为了比较接受益生菌和接受标准护理的患者之间的发病率和严重程度.
- 评估益生菌补充剂在正牙治疗期间对患者舒适度的影响.
主要方法:
- 一项随机对照试验,涉及64名接受固定牙科治疗的患者.
- 参与者被分为对照组 (正牙) 和病例组 (正牙加Lactogum片).
- 数,疼痛水平和位置被记录并使用独立样本t测试 (P<0.05) 进行统计分析.
主要成果:
- 乳糖组显示,口腔的平均数量有统计学意义的减少 (P<0.001).
- 与对照组相比,Lactogum组的平均疼痛水平明显低于对照组 (P<0.001).
- 口腔和唇部粘膜是发育最常见的部位.
结论:
- Lactogum益生菌药片在减少创伤性口腔和与之相关的疼痛方面表现出有效性.
- 这些发现表明益生菌在改善固定牙科治疗期间的患者体验方面可能发挥作用.
- 需要进行更大规模的临床试验来验证这些初步结果并探索长期影响.
相关概念视频
01:26Peptic Ulcer Disease IV: Management
79
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
79
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
384
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
384
01:30Peptic Ulcer Disease I: Introduction
162
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
162
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
340
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
340
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
266
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
266
01:21Drugs for Treatment of Constipation-Predominant IBS
151
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
151